• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLSTENT ENDOPROSTHESIS; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLSTENT ENDOPROSTHESIS; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number 26280
Medical Device Problem Codes Positioning Failure (1158); Failure to Advance (2524); Material Deformation (2976); Material Integrity Problem (2978)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/24/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that stent damage occurred.The patient presented with advanced lung cancer with severe space-occupying lesion.Angiography was performed which revealed an over 85% stenosed target lesion located in the severely tortuous superior vena cava.The patient was placed in supine position and puncture was performed through the right femoral artery with a 10f puncture sheath.A 0.035 amplatz guidewire was then advanced to the lesion and pre-dilatation was performed with a 6x100, 8x100, and 12x80 mustang balloon catheters.Due to severe tortuosity of the blood vessel, the balloon retracted severely after crossing.Subsequently, a 14x90/9fr 75cm wallstent endoprosthesis was advanced to treat the lesion.However, after multiple attempts to cross the lesion, the stent could not be deployed.The device was removed and it was noted that the cover of the stent and the stent itself were damaged.Deployment was tested outside the patient body but there was difficulty encountered.The procedure was completed with another of same device.There were no patient complications reported and the patient's status was stable.
 
Event or Problem Description
It was reported that stent damage occurred.The patient presented with advanced lung cancer with severe space-occupying lesion.Angiography was performed which revealed an over 85% stenosed target lesion located in the severely tortuous superior vena cava.The patient was placed in supine position and puncture was performed through the right femoral artery with a 10f puncture sheath.A 0.035 amplatz guidewire was then advanced to the lesion and pre-dilatation was performed with a 6x100, 8x100, and 12x80 mustang balloon catheters.Due to severe tortuosity of the blood vessel, the balloon retracted severely after crossing.Subsequently, a 14x90/9fr 75cm wallstent endoprosthesis was advanced to treat the lesion.However, after multiple attempts to cross the lesion, the stent could not be deployed.The device was removed and it was noted that the cover of the stent and the stent itself were damaged.Deployment was tested outside the patient body but there was difficulty encountered.The procedure was completed with another of same device.There were no patient complications reported and the patient's status was stable.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: a 14x90/9fr uni plus 75cm was received for analysis.The device was received with the stent fully constrained in the correct position on the device.The investigator successfully deployed the stent without issue.A visual examination identified kinking to the deployed stent.The outer sheath was found to be kinked at more than one location.This type of damage is consistent with excessive force being applied to the device.The inner sheath was found to be kinked at the same location as the outer sheath.This type of damage is consistent with excessive force being applied to the device.The device was received with the stent fully constrained in the correct position on the device.The investigator successfully deployed the stent without issue.A visual examination identified kinking to the deployed stent at the same location as the sheath when it was mounted on the delivery system.A visual examination identified no damage or issues with the stent holder/cup or tip of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLSTENT ENDOPROSTHESIS
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16742988
Report Number2124215-2023-14994
Device Sequence Number5435491
Product Code MAF
UDI-Device Identifier08714729204015
UDI-Public08714729204015
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K152842
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/28/2024
Device Model Number26280
Device Catalogue Number26280
Device Lot Number0029310276
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/24/2023
Supplement Date Received by Manufacturer05/11/2023
Initial Report FDA Received Date04/14/2023
Supplement Report FDA Received Date06/02/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/29/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GUIDEWIRE: 0.035 AMPLATZ; GUIDEWIRE: 0.035 AMPLATZ
Patient Age80 YR
Patient SexMale
Patient Weight59 KG
-
-